APEMESH II - Perineal Reconstruction
Apemesh II - Perineal Reconstruction With Mesh Enhanced Gluteus Plasty
1 other identifier
interventional
30
1 country
1
Brief Summary
The objective of this pilot study is to assess the safety, functional outcome, feasibility and the potential benefits of synthetic mesh strip and gluteus flap reconstruction in perineum in case-control setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 3, 2021
CompletedStudy Start
First participant enrolled
March 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFebruary 1, 2024
January 1, 2024
12 months
February 22, 2021
January 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complications
Comprehensive complication index
30 days
Secondary Outcomes (9)
Surgical site infections
30 days
Reoperation rate
30 days
Operative time
30 days
Length of hospital stay
30 days
Costs of treatment materials
30 days
- +4 more secondary outcomes
Study Arms (1)
Gluteus plasty enhanced with Progrip self gripping mesh
EXPERIMENTALAll study patietns will have a gluteus enhanced plasty after abdominoperineal reconstruction.
Interventions
Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.
Eligibility Criteria
You may qualify if:
- Curative intent abdominoperineal resection and permanent colostomy
You may not qualify if:
- Patient with a comorbid illness or condition that would preclude the use of surgery (ASA 4- 5)
- Immunosupression (cortisone \>10mg/day) or severe malnutrition (BMI \<20)
- Diabetes with 1 or more organ damage
- Dialysis treatment
- Hepatic cirrhosis Child-Bugh B-C
- Potentially curable resection not possible
- Patient undergoing emergency procedures
- Metastatic disease
- Vaginal resection, pelvic exenteration and sacrum resection
- Vaginal perforation
- Pelvic abscess or perforated tumor
- Pregnant or suspected pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oulu University Hospital
Oulu, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Tero Rautio, M.D. Ph.D.
Oulu University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 22, 2021
First Posted
March 3, 2021
Study Start
March 19, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
February 1, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share